Trambas Christina, Gallo Federico, Pende Daniela, Marcenaro Stefania, Moretta Lorenzo, De Fusco Carmela, Santoro Alessandra, Notarangelo Luigi, Arico Maurizio, Griffiths Gillian M
Sir William Dunn School of Pathology, South Parks Rd, Oxford OX1 3RE, United Kingdom.
Blood. 2005 Aug 1;106(3):932-7. doi: 10.1182/blood-2004-09-3713. Epub 2005 Mar 1.
Mutations in the perforin gene have been found in patients with hemophagocytic lymphohistiocytosis (HLH), a rare autosomal recessive disease. We describe a patient expressing perforin with amino acid changes A91V and W374X. The ability of cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells to lyse target cells is greatly reduced. Here we demonstrate that perforin from this patient is not recognized using an antibody raised against native perforin (deltaG9), but is readily detected using an antibody raised against a peptide epitope (2d4), suggesting that the epitope recognized by deltaG9 is destroyed by the change at A91V. Immunoblotting reveals no protein corresponding to the truncated transcript encoded by W374X, revealing that only perforin with the A91V change is expressed in CTLs from the patient. Patient CTLs show bands corresponding to the immature and intermediate forms of perforin, but the mature active form of perforin is absent or barely detectable. The conformational changes and impaired cleavage of A91V perforin are likely to explain the reduced cytotoxicity in CTLs and NK cells from this patient and are likely to contribute to the pathogenesis of HLH.
在噬血细胞性淋巴组织细胞增生症(HLH)患者中发现了穿孔素基因突变,HLH是一种罕见的常染色体隐性疾病。我们描述了一名表达穿孔素的患者,其氨基酸发生了A91V和W374X的变化。细胞毒性T淋巴细胞(CTL)和自然杀伤(NK)细胞裂解靶细胞的能力大大降低。在此,我们证明,使用针对天然穿孔素(deltaG9)产生的抗体无法识别该患者的穿孔素,但使用针对肽表位(2d4)产生的抗体很容易检测到,这表明deltaG9识别的表位被A91V处的变化破坏。免疫印迹显示没有与W374X编码的截短转录本相对应的蛋白质,表明该患者的CTL中仅表达具有A91V变化的穿孔素。患者的CTL显示出与穿孔素的未成熟和中间形式相对应的条带,但穿孔素的成熟活性形式不存在或几乎检测不到。A91V穿孔素的构象变化和裂解受损可能解释了该患者CTL和NK细胞中细胞毒性降低的原因,并可能导致HLH的发病机制。